Figures
Abstract
Introduction
Medication errors are a leading cause of patient harm and account for thousands of deaths and injuries annually. While medication safety efforts have primarily targeted hospital settings, community pharmacies are also prone to such errors due to their high patient access and utilisation. This review utilised a meta-ethnographic qualitative approach to synthesise findings from available primary qualitative research about the causes of medication safety issues and errors in community pharmacies as well as the contributing factors.
Materials and methods
This meta-ethnographic systematic review was conducted in line with Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) and the meta-ethnography reporting guidance (eMERGe) and framework and registered on PROSPERO. Eligible studies were identified using a comprehensive search strategy across multiple databases and grey literature sources, without language or date restrictions. Qualitative data were synthesised using Noblit and Hare’s seven-phase meta-ethnographic approach, generating third-order constructs that captured underlying causes of medication errors in community pharmacies. Confidence in the findings was assessed using the GRADE-CERQual framework.
Results
Thirteen studies were included in the review with the majority from the United States and England. Most studies (n = 10) used qualitative research designs while two studies utilised a mixed-methods approach. Through meta-ethnographic synthesis, five third-order constructs (themes) were developed to represent the factors contributing to medication errors in community pharmacies. These themes included: 1) pharmacist-related factors, 2) the environment within the pharmacy 3) management and financial related factors 4) organisational and social environment within the pharmacy and 5) challenges with digital technologies.
Conclusions
This meta-ethnographic systematic review identified five themes contributing to medication errors in community pharmacies. The review findings offer valuable insight for guiding the design of future tailored safety initiatives. Understanding the complex interplay between these contributing factors is essential for enhancing medication safety and informing future research and practice in real-life community pharmacy settings.
Citation: El Hajj MS, Robinson-Barella A, Husband A, Todd A (2026) Causes of medication errors in community pharmacies: A meta-ethnography and systematic review. PLoS One 21(6): e0349120. https://doi.org/10.1371/journal.pone.0349120
Editor: Ali Haider Mohammed, Universiti Monash Malaysia: Monash University Malaysia, MALAYSIA
Received: September 21, 2025; Accepted: April 26, 2026; Published: June 10, 2026
Copyright: © 2026 El Hajj et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
According to the World Health Organization (WHO) 2023 data, approximately 10% of patients experience harm while receiving health care with unsafe practice causing over 3 million deaths occurring each year worldwide. Medications account for more than 50% of this harm [1]. Medication-related harm impacts about one in every 30 patients receiving health care and over a quarter of these incidents are considered severe or potentially life-threatening [2]. A medication error is defined as “any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health-care professional, patient, or consumer [3]. These events could be related to professional practice, products, procedures, and systems and can occur at any stage of the medication-use process, including prescribing, dispensing, administration, education, monitoring, and use [3]. Medication errors can cause adverse drug events, leading to improper medication use, prolonged hospitalisation and adverse consequences for patients. They also cost globally an estimated 42 billion USD annually [4]. Medication safety refers to the procedures used in different healthcare settings to decrease the risk for medication errors [5]. Numerous organisations have started initiatives and published policies to improve medication safety. For example, the WHO launched the third Global Patient Safety Challenge on Medication Safety ‘medication without harm’ with the aim of having a global commitment and action to decrease medication-related harm. The aim of this initiative was to reduce errors by targeting the harm resulting from risky medical practices [4].
Although hospital settings have received a lot of attention when it comes to medication errors and medication safety, non-hospital settings specifically community pharmacies, are also a concern [6]. Due to the extended opening times, geographical accessibility, and convenience, community pharmacies are one of the most frequently used healthcare facilities [7]. For instance, in England, it is estimated that 1.6 million visits are made to community pharmacies every day, with approximately 43 million visits annually for health-related concerns [8].
In addition to dispensing prescribed and over the counter medications and delivering medication therapy services, community pharmacies play an important role in delivering clinical and health promotion interventions [9–14]. These include the management of chronic diseases such as diabetes and hypertension, treatment of minor illness, smoking cessation programs, immunisations, and contraception services [9–14]. Medication errors in community pharmacies involve both prescription and OTC medications and include but not limited to prescription commission errors (e.g., incorrect medication, dose, dosage form, or route of administration), prescription omission errors, and dispensing errors. Dispensing errors may involve content errors (such as dispensing the wrong strength or dosage form) and labelling errors [15].
While there is no estimate of the global incidence of medication errors in community pharmacies, a recent systematic review of 73 studies about the prevalence, nature and severity of medication errors in community pharmacies indicated high variations in error rates and types in different geographical regions [15]. For instance, within the Europe and Central Asia region, the prescribing error rates ranged from 0.062% in a study in the United Kingdom [16] to 32.84% in a study in Poland [17]. While in North America, dispensing error rates varied from 0.075% in a study in New Jersey in the United States [18] to 24% in another American study in New York, New Jersey and Florida [19]. In South Asia, a study from India reported a prescribing error rate of 6.09% [20]. In the Europe and Central Asia region, dispensing error rates ranged from 7.1 undocumented dispensing errors per 100,000 dispensed prescriptions in Finland [21] to 3.3% in the United Kingdom (UK) [22]. In the Middle East and North Africa region, dispensing error rates varied from 0.8% in two studies conducted in Yemen [23,24] to 36.7% in a study in Iran [25].To promote medication safety and prevent medication errors, it is crucial to understand, recognise and target the factors that contribute to errors in community pharmacies. Diverse descriptive studies and reports highlighted several important contributing factors for medication errors across the medication use process in community pharmacies [4,26–29]. For instance, these factors could include work environment factors (e.g., staffing levels and workload), organizational and management factors (e.g.,: financial resources and organizational structure), team factors (e.g., supervision, and team structure), task and technology factors (e.g., decision support tools), individual factors (e.g., knowledge and skills) and patient-related factors (e.g., medical condition and language) [30].
Additionally, some qualitative studies explored how these factors interact in community pharmacy settings. For instance, Phipps et al., in 2009, examined how interactions between people, tasks, equipment and organisational factors can cause medication errors in community pharmacies in the North West of England [31]. Using focus groups with community pharmacists, various themes were generated in relation to the impact of social and organisational factors on medication safety: relationships involving the pharmacist, demands on the pharmacist and management and governance of pharmacists [31]. Furthermore, Harvey et al., investigated risks in prescription dispensing in community pharmacies in England by considering the links between the important elements of the medication dispensing process [32]. Using observations, shadowing and interviews, key categories included: people and their approach to work, management structures, physical infrastructure, engagement with technologies, attitudes towards safety and prescriber influences [32]. Similarly, Al Juffali et al., examined the medication safety problems linked to medication supply in community pharmacies in the Kingdom of Saudi Arabia using focus groups and individual interviews. Several themes were identified, based on the Human Factor Framework (HFF), including commercialism and commercial pressure, patient factors, Illegal supply of medications, lack of enforcement of regulations, the healthcare system, patient medication taking behaviour and other themes [33].
While individual qualitative studies have provided essential information about the factors affecting medication safety in community pharmacy, this evidence remains fragmented. There still remains a need to gain further and deeper insight of how and why these errors occur to better inform improvement efforts. A qualitative evidence synthesis approach, such as meta-ethnography, can assist in extending beyond original studies and systematic reviews to develop higher order interpretations and identify target areas for improving medication safety in community pharmacy settings.
Objectives
This review utilised a meta-ethnographic approach to synthesise findings from available primary qualitative research about the causes of medication safety issues and errors in community pharmacies, as well as the contributing factors. The review findings can potentially give a perspective into designing approaches to mitigate potential medication errors from occurring in community pharmacies.
Materials and methods
This meta-ethnographic systematic review has been conducted and reported according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [34] and the meta-ethnography reporting guidance (eMERGe) and framework [35] (S1 and S2 File). The review was registered on the International Prospective Register of Systematic Reviews (PROSPERO) at the Centre for Reviews and Dissemination, University of York, United Kingdom (ref: CRD42024562734).
Eligibility criteria
The review inclusion criteria were formulated using the SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research type) framework, as follows:
- S: adult or paediatric patients who are receiving care in community pharmacies;
- PI: medication errors or medication safety problems;
- D: published literature and grey literature of qualitative design reporting primary qualitative data or mixed methods design where sufficient qualitative data is available;
- E: causes of medication errors or factors that contribute to medication errors;
- R: peer reviewed journal articles and grey literature including reports and briefings, conference proceedings and theses.
Reviews, letters, editorials, commentaries, clinical trials and quantitative studies were excluded [36]. Articles were not excluded from this work based on study quality. Language and date restrictions were not applied. A community pharmacy setting was defined as ‘a healthcare facility that provides pharmaceutical and cognitive services to the community’ [37].
Data sources and search strategy
The following databases and search engines were systematically searched from inception until 31 January 2025: MEDLINE (Ovid), Embase (Ovid), Cochrane Central Register of Controlled Trials, ISI Web of Science, Scopus, Database of Abstracts of Reviews of Effects (DARE), Health System Evidence, Global Health Database, Joanna Briggs Institute Evidence-Based Practice Database, Academic Search Ultimate, ProQuest Dissertations, PROSPERO, Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCO), ScienceDirect (Elsevier), Health Management Information Consortium (HMIC), and Google Scholar. Different search terms were used according to the searched database. Manual backward citation searching of the references of all included articles and other relevant review articles was conducted. Grey literature was also searched through abstracts of conference proceedings and dissertation abstracts. Data sources included theses.com and ProQuest. S3 File outlines the data sources and the search strategy in details.
Study selection
All obtained references were exported to EndNote©20 reference software manager for duplicates removal and screening. MH (Maguy El Hajj) evaluated study titles and abstracts in accordance with the review’s inclusion criteria. Eligible studies were exported to Rayyan© software where full-text screening was undertaken by a single researcher (MH) and independently checked by senior authors AT (Adam Todd) or AH (Andy Husband). Disagreements were resolved through dialogue and achievement of mutual agreement.
Data extraction and quality appraisal
A data extraction tool was designed for extracting data from included studies including: author(s), publication year, design, setting, country, aims, population, data collection, results including themes, subthemes and authors’ quotes in addition to other relevant information. These data were extracted by one researcher (MH) and checked independently by another researcher (AR-B). Disagreements were addressed in consultation with the senior authors (AH and AT) until consensus was reached.
The quality of each included study was evaluated by MH using Critical Appraisal Skills Programme (CASP) tool for qualitative research [38].
Analysis and interpretative synthesis
Meta-ethnography was initially developed by Noblit and Hare [39] and is frequently utilised in health and medical research [40–45]. In order to obtain a thorough knowledge, and to guide the creation of more comprehensive concepts, meta-ethnography is an interpretive and inductive methodology that stimulates researchers to comprehend and apply concepts, themes, and metaphors from other studies [35,39]. It was selected as the approach for qualitative evidence synthesis in this study as it allows for interpretative synthesis rather than just aggregating the results of qualitive studies, assists in forming advanced conceptual insights and helps unveil cross study explanations in relation to medication safety in community pharmacy settings [40–45].
The seven phases of the meta-ethnography approach are depicted in Table 1.
Determining how studies are related. An excel sheet outlining the results extracted from the included studies was created, including quotations (named ‘first-order constructs’) and the original authors’ interpretations (named ‘second-order constructs’). This sheet helped in comparing the results. Two reviewers (MH and AR-B) then discussed how these constructs are related (Step 4).
Translating the studies into one another. Reciprocal translation (i.e., chronological comparison of first- and second-order constructs across individual papers) was used to develop new themes and subthemes (named ‘third-order constructs’) [30]. This method entails comparing the themes identified in study 1 with those from study 2, followed by a comparison of the combined themes with the findings from study 3, and subsequent studies. This iterative approach continued until all studies were synthesised. (Step 5)
Synthesising translations and expressing the synthesis. Third-order constructs were generated by synthesising first-order constructs (i.e., participant direct quotations) and the second-order constructs (i.e., original study authors’ interpretations) (Steps 6 and 7). The third-order constructs aim to extend beyond the initial author interpretations of studies to have an overall understanding of the causes of medication errors in community pharmacies.
To align with the reporting guidance of meta-ethnographies, the term ‘theme’ was used to refer to third-order constructs, and ‘sub-themes’ to denote third-order construct sub-themes [46].
Confidence in the synthesised findings
The GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative Research) approach was used to assess the confidence in our results [47]. This approach includes four components methodological limitations of included studies, the coherence of the qualitative evidence synthesis findings, the adequacy of data used to support the review finding, and the relevance of the included studies to the review question. According to the results of CERQual, the overall confidence is categorised into three levels: high, moderate, and low [47].
Results
Overall, 19,625 eligible studies were identified. After exclusion of duplicates and irrelevant articles, 14,183 studies were screened of which 11 studies met the review inclusion criteria. Four more studies were found through citation searching, resulting in a total of 15 individual studies included in the systematic review (Fig 1). Two articles were excluded from the meta-ethnography synthesis as they were unpublished theses [48,49]. Thirteen articles were included in the meta-ethnography synthesis.
Studies characteristics
A summary of the included studies’ characteristics is provided in Table 2. The studies were conducted across different countries, including five in the United States [50–55] and five in England [31,32,48,49,56]. Individual studies were carried out in New Zealand [57] and Kingdom of Saudi Arabia [33]. Moreover, one study originated from both the United States and Puerto Rico [58] while another study covered England and Wales [59]. Most studies (n = 10) used qualitative research designs [31–33,49,52,53,55–57,59], while two studies utilised a mixed-methods approach [48,51]. Duration of data collection varied from 2 months [52] to 19 years [57]. Various methods of data collection were employed with nine studies using a combination of approaches [32,33,48–50,52–54,56]. Interviews were the most frequently used method (n = 8 studies) [32,33,48,49,53–55,59], followed by observations or diary fields (n = 4 studies), [32,52–54] focus groups (n = 3 studies) [31,33,56] and think-aloud protocols (n = 2 studies) [52,53].
Findings: Reporting outcomes, synthesising translations and developing themes and sub-themes
Five third-order constructs (termed ‘themes’) were developed in relation to the factors and/or causes of medication errors in community pharmacies (Fig 2). Each theme is outlined in a separate table and includes:
- Pharmacist-related factors (Table 3)
- The environment within the pharmacy (Table 4)
- Management and financial related factors (Table 5)
- Organisational and social environment within the pharmacy (Table 6)
- Challenges with digital technologies (Table 7)
Theme 1: Pharmacist-related factors
This theme emphasised the perceived lack of pharmacist knowledge, skills, and experience and attributed this as a factor contributing to medication errors in community pharmacies. In two studies, participants described community pharmacists as being inexperienced and lacking competence [33,57], with one participant sharing beliefs that standard operating procedures (SOPs) could or should be followed to mitigate potential errors [57].
“Unfortunately [the pharmacy] was unaware of [Mr B’s] relative lack of experience, which, if known, could have prompted the need for [Mr B] to read [the pharmacy’s] SOPs. The employment agencies concerned have been spoken with regarding this lack of information, as it is they who are advertising these pharmacists as being fit for purpose, and the agencies have a professional responsibility to their clients to supply competent locum pharmacists.”(HDC13- Advisor/Pharmacist) [57]
Another participant described an example where a pharmacist was unaware of the availability or existence of specific medications or their strengths, [57] which could have contributed to toxicity or under-dosed treatment as a result of the error.
“…a major reason for both dispensing errors was that pharmacy staff were unaware at the time of dispensing that both Recormon and tacrolimus came in different strengths. (HDC09-Provider/ Pharmacist)” [57]
Another participant described a scenario in which a pharmacist, who had been employed at the pharmacy for only 10 days, was required to dispense a prescription. Due to the lack of familiarity with the established patient population in the pharmacy and prescribing patterns, the pharmacist had to rely primarily on the patient’s prior prescription records for uncommon medications [57]. This reliance on historical medication records increases the risk of dispensing errors, particularly when the records are incomplete or contain inaccuracies that have not been rectified.
“[the pharmacist] had been working at the pharmacy for only 10 days when Ms A’s script was dispensed, which would have made her more reliant than usual on previous script history for unusual scripts.” (HDC26-Advisor/Pharmacist)” [57]
Theme 2: The environment within the pharmacy
This theme considers how the following subthemes could contribute to the risk of medication errors: i) limitations of pharmacy space and medication storage, (ii) challenges with medication packaging, and iii) managing typical interruptions within the pharmacy.
Subtheme: Limitations of pharmacy space and medication storage.
Participants described ways in which the layout of the pharmacy, specifically the design and configuration of the dispensary area, could predispose to risk of medication errors [31,57]. For example, participants described how organisation and tidiness of shelving systems is important to avoid incorrect ‘picking’ errors [31,57].
“You’ve got to have a tidy dispensary or things do get muddled up and then when you’re working fast you’re just leaping around, grabbing things off the shelf, and unless things have been put in the correct place it’s so easy [to make a mistake] [Locum pharmacist, Group 9]” [31]
In two studies, inappropriate medication storage conditions were identified as a causative factor for medication errors [33,57]. Participants raised concerns about disconnecting electricity at night and reconnecting it in the morning, noting that such temperature variations could compromise the quality of medications and potentially lead to their degradation [33]. They also highlighted the issue of storing medications with similar names in close proximity on shelves increasing the risk of errors [57].
“It is a matter of saving electricity just like groceries. At night, they disconnect the refrigerator containing milk to save electricity, and when they come back in the morning, they turn on the electricity. (Male pharmacy user group-4)” [33]
Subtheme: Challenges with medication packaging.
Participants also expressed concerns about the lack of standardised packaging and labelling in addition to frequent changes of subsidised medications by funded agencies [31,57]. These changes result in variations in appearance and nature of medications increasing the risk for dispensing errors [57].
“However, it should be pointed out that PHARMAC, the medicines funding authority, does make regular changes to the schedule of funded medicines. This often leads unexpected changes in the appearance and nature of various medicines as different manufacturers are subsidized for the same drug formulation. This situation adds an extra element of risk in today’s dispensing environment, and is an area where pharmacists must be eternally vigilant.”(HDC10- Advisor/Pharmacist) [57]
Subtheme: Managing typical interruptions within the pharmacy.
Across several studies, interruptions in the pharmacy were identified as critical contributors to medication errors in community pharmacy settings [31,32,51,53,56,57,59]. Participants frequently reported experiencing interruptions in workflow due to simultaneous demands such as patient consultations, pharmacy staff communications, ringing telephones, as well as work meetings and conference calls [31,51,53,56,57,59].
“They use being “salaried exempt” as a way to get free work done from the pharmacists. We are expected to go to work meetings and be on conference calls on our days off unpaid. We are made to rush and do the job of a pharmacist and tech to keep the pharmacy afloat from understaffing. The open environment, being constantly distracted from patients interrupting us (open floor plan), and the phones ringing off the hook with not enough bodies to answer the phone leads to a truly stressful environment that makes it difficult to safely multi-task. More mistakes are being made.” [51]
One study reported that watching television in the pharmacy during medication dispensing is a source of distraction for pharmacy staff [32].
“Viewing television seems to be part of work culture. From about 9.15 to noon, the staff was viewing television whilst dispensing medicines. During the television viewing period, attention of the staff was very distracted. JH recorded: 9.18. There is a television playing on the dispensing counter... There is constant attention on the TV. At one point a customer was left waiting as Counter Assistant (CA) was occupied watching TV. She (CA) has been reminded that a customer was waiting. The television was firmly stationed on the front counter and appeared to be part of the pharmacy’s hardware. To confirm this, a researcher collecting data for a different work stream of this project reported watching television (during his lunch break) at this pharmacy” [32]
Theme 3: Management and financial related factors
The following subthemes explored the pressures discussed by participants relating to staffing, work-loading and management of the community pharmacy, in addition to financial pressures. This theme included: i) workforce and resource pressures ii) management pressure on pharmacists, and iii) impact of commercial, insurance and financial pressures on pharmacist and physician practices.
Subtheme: Workforce and resource pressures.
Staff shortages, as well as difficulties in recruiting and retaining adequately trained and qualified pharmacy personnel, were recognised as significant contributing factors to medication errors in three studies [51,57,59].
“[Mr B] said the pharmacy was ‘extremely busy’ and he lamented the difficulties in attracting pharmacists to our rural pharmacy’. This is by no means an excuse, but is a very important context for the error.” (HDC09-Advisor/ Pharmacist) [57]
“Not enough help! Quality help! Takes a long time to train someone and then they leave for better pay and less stress” [51]
An additional strain that was discussed by several participants related to workload pressures, including volume of work and long working hours, as being contributors for medication errors [32,51,56,57,59]. Pharmacists often reported managing multiple responsibilities, such as dispensing prescriptions and consulting with multiple patients concurrently. Participants described how this high workload frequently led to rushing prescription processing without a proper clinical check, increasing pharmacist stress and potentially increasing the risk of medication errors [32,33,51,56,57,59].
One participant expressed concerns of making medication errors due to overworking and not taking breaks. The participant also offered recommendations on the enhancement of workplace conditions especially for pharmacists who are pregnant and/or post-partum. Suggestions related to allocation of time and space for resting and breastfeeding to potentially reduce medication errors as a result of pressure and over-working [51].
“Giving pharmacists a 30 minutes lunch break or 1 hour for pregnant moms to pump and eat can make a huge impact positively in work conditions. Pregnant moms not able to sit or drink water working for more than 12 hours can cause a serious negatively health impact to which I am concerned. When I was pregnant with my first child. I wasn’t able to eat or use the bathroom because I am constantly interrupted with immunizations. i.e., influenza shots, doctor’s calls, patient questions, telephones, technicians needing help, clerk not knowing what to do. The list goes on. Having a chair in every pharmacy for pregnant moms will surely help the mom with her health and making sure her health is taken care of. My biggest concern is making medications error from over working and not taking breaks due to fear of falling behind. Even worse, losing a baby from constantly standing and not able to use the bathroom which lead to UTI which in return does harm to the baby and the mom. The work conditions in community pharmacy is very harsh and dangerous to work in. We cannot afford to make medications error and pharmacists need to eat. We are not robots and I need to eat for my growing baby.” [51]
Moreover, pharmacists also articulated it was challenging to find time for professional development due to workload pressures [33].
“He has long working hours and that leads many pharmacists to not refresh their information.[by attending workshops for continuing their education], …there is no role for the Ministry to update your information. For example, the pharmacist (Community pharmacy group-4) graduated in 1986 and necessarily many improvements[updates] have taken place since that time.” (Community pharmacy group-2) [33]
In several studies, pharmacists indicated the financial difficulties faced [31–33,51], with funding [33] and wage and staff cuts [31] being examples that then impacted on the risk of errors occurring. One study, in particular, reflected specifically on balancing the profitability of a pharmacy as a business alongside needing to ensure patient safety [33]. In this study, participants described the pharmacists’ frustration with having to work on a Friday, which is typically considered a weekend in Saudi Arabia [33].
“I don’t expect anything from the pharmacist, because all pharmacists are frustrated and this is due to their low salaries and the nature of their work. In a pharmacy, I noticed a pharmacist working in the middle of a hot day on Friday and he used to walk three or four kilometres.” (Male pharmacy user group −5) [33]
In one study, there was description of how decreased investment in automation and safety-enhancing pharmacy operations may also contribute to medication errors [51].
“Pharmacies used to be able to afford safety features and automation but even that cannot longer be afforded” [51]
Subtheme: Management pressure on pharmacists.
Pharmacists underscored the tension between management-directed performance metrics and patient-centred care in pharmacies [32,33,51]. Pharmacists reported feeling compelled to meet prescription targets, rather than focusing on patient outcomes; many described how they may face disciplinary actions if they were non-compliant with reaching targets [33,51].
“Problems between you and the owner arise; he [the owner] asks what happened … [you] pay a penalty, close the pharmacy and your license is suspended. These problems face us and affect our work.” (Community pharmacy group-4) [33]
In two studies, participants reported it was a struggle to provide comprehensive consultations, such as systematic ‘Medication Use Review (MUR)’, due to time limitations and management surveillance [32,51].
“It is conflicting, because you care about your patients and you think it’s not about targets. Like the old lady that came in and she was talking about her painkillers when she has a headache. I noted that down, I could use that as an MUR in the sense that I did sort of tell her that she’s not supposed to be taking them all the time. It’s good that you can use it, because it’s exactly what it is, you are telling the patient how to use them and advising them about it. Those are the little things that I have to concentrate on and pick up on to meet my targets.” [32]
In these studies, pharmacists also indicated that their clinical expertise was undermined when their professional judgment was being questioned for the purpose of enhanced patient satisfaction [32,51]. They also expressed frustration over the management holding them responsible for patient complaints, even if they had valid reasons for refusing to fill prescriptions or dispense medications [32,51].
“If I get a complaint I could be written up even if I had a valid reason that they had to wait I am always in the wrong and must call to apologize even if they were wrong the patient is never wrong and my professional judgment on not filling or refusing a patient is constantly being questioned and must be defended against a patient who doesn’t know anything about my job or the logistics of pharmacy billing dispensing and law.” [32]
Subtheme: Impact of commercial, insurance and financial pressures on pharmacist and physician practices.
Participants conveyed that some pharmacists and physicians were affected by financial incentives from pharmaceutical companies or driven by their profit motives leading to prescribing and dispensing of specific medications rather than addressing patient needs [31,33]. If medications dispensed are inappropriate for the patient, they may place the patient at risk of harm.
“In our country, the pharmacist gives you the medication that is suitable to him or the medication for which he receives a commission, you go to the pharmacist you say you have a headache he gives you Fevadol instead of Panadol [generic substitute] for example he gives you the medication that suits you, who he is an agent for it or gives him a commission for. Even in clinics, the representative of the company comes to the physician and gives him the new medications with tickets and gifts and the physician prescribes the medications.” (Male pharmacy user group-5) [33]
Additionally, participants discussed the impact of insurance companies on physicians’ prescribing behaviours indicating that physicians overprescribed medications to increase the insurance claims [33].
Moreover, they shared the role of Pharmacy Benefit Managers (PBMs) in restricting patients’ choices forcing them to use certain chain pharmacies, that are understaffed, therefore potentially increasing the risk for errors [51].
Theme 4: Organisational and social environment within the pharmacy
This theme includes the following subthemes i) error mitigating policies and processes ii) human errors in pharmacy practice iii) communication challenges and iv) unrealistic expectations about pharmacist practice
Subtheme: Error mitigating policies and processes.
In two studies, participants reported instances of inadequate and outdated SOPs and policies; in the examples they shared, these related to high-risk scenarios such as methadone dispensing, controlled drug storage, and incident management [57,59].
“However, I note that the pharmacy had preferred practices that it encouraged pharmacists to employ relating to its checking procedures that were not included in the SOPs at the time of events. I am critical of the pharmacy that its SOPs were not up to date to reflect its current practices.” (HDC31-HDC) [57]
In five studies, participants identified that medication errors were concealed and underreported, rather than being recognised and addressed, suggesting failure in good clinical governance [31,32,51,57,59].
“I know other pharmacists who [...] definitely stick to the rules, no matter what, and are not gonna bend ‘em. Then some people who kind of just squeeze past them. So it does depend on the person [Pharmacist, Group 2]” [31]
“There are colour baskets red, white and blue, which are supposed to be used to organize dispensing, but I have just been informed that this procedure is not usually followed.” [32]
“In my view, the number of errors at the pharmacy, and the fact that these have been made by more than one staff member, indicate a systemic problem with regard to staff failing to follow the pharmacy’s SOPs.” (HDC14-HDC) [57].
Differences in policy adherence were also noted between chain and independently-ran pharmacies. In two studies, participants shared their perspectives of chain pharmacies maintaining a firmer compliance to guidelines to ensure standardisation across all branches, compared to those that were independent [31,33]. Moreover, they stated that chain pharmacies provide training for their pharmacy staff to emphasise the implementation of regulations [31,33].
“The advantage of notifying the Head Office [of a chain] is that they then cascade the information to everybody so that every store can then separate the Xalacom and Xalitan in the fridge so that it doesn’t happen, so you’re actually avoiding the error ever happening [Locum pharmacist, Group 9]” [31]
Participants also noted across three studies the challenges of balancing adherence to protocols with the need for flexibility in clinical decision making and personalised patient care [31,33,59]. Some pharmacists indicated their readiness to bypass SOPs where compliance might not adequately address the patient’s needs, especially in humanitarian or critical cases or cases involving medication loaning [31,33,59].
“I sometimes think they’re not very helpful for patients. If you’ve got a protocol and you’ve got to do it a certain way, but then you can’t, say a checking one [...] do you break it for the benefit of the patient, even though you know you shouldn’t? [Pharmacist, Group 2] [31]
“I dispense everything; I am a pharmacist regardless of the laws, when you have a patient in front of you needing to be treated it would be difficult especially if the patient is poor and needs assistance you do not help him; for humanity” (Community pharmacy group-4) [33]
Furthermore, in one study pharmacists indicated that despite promoting a learning-centred work environment, a blame culture still persisted with emphasis on who committed the error, which could hinder accountability and transparency in reporting [31].
“[We] were taught, certainly in my era, at College, you did not make mistakes, you covered them up, that was the history. I had a boss who I could have killed because he did make mistakes but he refused to admit it. [...] [I] went in to the dispenser and said “Look, ignore him, we all make mistakes, we check each other” [Locum pharmacist, Group 9] [31]
Participants in three studies also reported poor error reporting practices reflecting inconsistent, informal and non-transparent approaches for reporting [31,56,57].
“Amending records in this way without identifying that the amendment has been made retrospectively is very poor practice. Furthermore, by making amendments to the records in this way, Mr B removed the record of what actually occurred, which is also unacceptable.” (HDC14-HDC) [57]
Subtheme: Human errors in pharmacy practice.
Three studies identified human errors as significant risks to patient safety [31,57,58]. These errors encompassed inattentiveness, forgetfulness, inadequacies in labelling, packaging, and bagging in addition to misidentification of patients and medications and insufficient assessment of patient-specific factors before medication dispensing [31,55,57,58].
“In this case, it appears that human error or haste on the part of Mr D (or another pharmacy staff member) caused Mrs A’s prescriptions to be bagged incorrectly.” (HDC08-HDC) [57]
Subtheme: Communication challenges.
In two studies, participants expressed a key challenge faced by pharmacists: the lack of communication among pharmacy staff and within and between branches of chain pharmacies [31,56]. Furthermore, pharmacists were often concerned about not being informed of recent errors and incidents [31,56].
“I [once] had an issue with methadone, [...] I did not agree with what the pharmacists had done the previous week and they’d done nothing about it all week when they had time to sort it out and then they didn’t even tell me in advance of me going, I walk in on the Saturday and get stuck with the real issue, do you give it, don’t you give it. And you’re dealing with something that’s quite, you know, can change that person quite a lot, and you’re thinking, “Well, where do you stand?” [Locum pharmacist, Group 3] [31]
An additional issue that participants indicated in one study is the breach of patient confidentiality through verbal communication particularly in small community pharmacies [53].
“There is more potential to break HIPAA [U.S. Health Insurance Portability and Accountability Act, a legislative act that protects patients’ health information]. Because we have a small pharmacy, I’ll be over here [pointing to opposite side of pharmacy] and I’ll say, ‘Hey, can you pull a prescription for [John Doe],’ or whomever the patient may be. I’ll say it across the pharmacy, so the other patients know who the person is. Whereas with the paper prescription, it’s there and you don’t even have to say anything.” [53]
Moreover, some pharmacists conveyed feeling demoralised as a result of strict company policies that hinder open communication and undervalue the importance of feedback. They also shared feeling nervous when addressing issues that include colleagues about potential negative consequences [31].
“I think you tend to get more demoralised staff in a company and more negative on feedback and communication to a well-run independent sometimes, because I think they’re sort of all put into a block and they can be boxed if you’re not careful in a company” [31]
Additionally, across three studies, participants identified communication gaps between pharmacists and patients [33,53,57] with language barriers being one of the contributing factors.
“I came across someone who didn’t know whether the medication was for constipation or diarrhoea. He said he wanted something for diarrhoea. The matter is that he didn’t want something for diarrhoea; he wanted something to cause diarrhoea. In brief, language has an effect.” (Community pharmacy group-4) [33]
In one study, some pharmacists highlighted that these communication issues are more common with e-prescriptions compared to paper prescriptions. Patients often perceive that e-prescriptions are instantly processed resulting in their dissatisfaction as a result of the delay in receiving their medications [53].
Participants also reported an argument about pharmacists’ role in patient education. Some believed that they should proactively offer patient education even if the patient does not ask while others argued that education should only be offered upon patient request. This discrepancy in expectations can potentially affect medication safety [33]. Participants also indicated having communication challenges between pharmacists and prescribers, particularly when contacting prescribers to clarify prescriptions [33,53].
“There is another concern in that it doesn’t always print the information of the doctor where they’re currently at. If you have a doctor working a walk-in or an E.R. [emergency room] and you get a prescription from them, it sometimes lists their office phone number. Then if you have a question on it and you try to call the phone number that’s on the e-prescription sometimes they’re like, ‘Oh, well they’re not here today.’ Then you have to call around or they have to bounce you around from person to person until you can find where they actually are practicing. So it makes it harder to track them down.” [53]
Subtheme: Unrealistic expectations about pharmacist practice.
Pharmacists reported having sometimes tense interactions with patients resulting in pressure affecting their dispensing practices and decisions [33,57]. In one study, participants described a case scenario in which patients pressured pharmacists to dispense antibiotics by the strip, a practice that is considered a violation in Saudi Arabia. [33].
“Originally, it is prohibited by the Ministry of Health to dispense antibiotic as a strip and if this is done it would be a violation and in case of not dispensing them in this form, the patient will go to a second, third and fourth pharmacy until he finds what he wants” (Community pharmacy group-1)” [33]
Moreover, in three studies, pharmacists highlighted patients’ lack of understanding of the dispensing process and their expectation that an effective pharmacist is one who fills prescriptions quickly without considering accuracy and quality. This created an extra pressure on pharmacists as they often felt obligated to prioritise patient satisfaction over appropriate medication dispensing and consultation [31,51,59].
“I think we’ve got to get away from the idea that a good pharmacist in the view of the public is one who gets the medication out quickly. [...] They just assume that it’s going to be correct but they don’t rank the actual quality of the dispensing in any of it, they put speed at the top [Locum pharmacist, Group 9]” [31]
Theme 5: Challenges with digital technologies
This theme includes these subthemes i) prescription input error, system translation and incompatibility issues ii) software limitations, including e-prescription control and management of outdated notes and prescriptions and iii) absence of automation and technology in community pharmacies and limited integration with other healthcare institutions.
Subtheme: Prescription input error, system translation and incompatibility issues.
Pharmacists listed several challenges associated with e-prescription systems, including input errors by medical staff, discrepancies between the pharmacy and the prescriber systems, and confusion in prescription details [50,52,54]. As a result of these challenges, several medication errors were undetected by pharmacists and reached patients [50].
“Pharmacist: If we’re searching and it’s not in our system exactly like it’s in the doctor’s system, even a patient name, for example, it won’t come up with that patient. If it’s, say, Cindy Smith but, at the doctor’s office, but we have her entered as Cynthia Smith, it won’t search for Cynthia because it’s searching for Cindy Smith. So then you have to delete out all that information and search for it. Same thing with the drug. If, say, in the doctor’s system it says magnesium citrate, and in our system, it says mag citrate, it won’t find the mag citrate because it’s abbreviated differently than what the doctor’s office says. So you have to kind of do a modified search in order to find the right drug.” [54]
Subtheme: Software limitations, including e-prescription control and management of outdated notes and prescriptions
Five studies identified challenges with pharmacy-based software as potential causes of medication errors [32,50,52,57,58], including lack of change-tracking features, technical malfunctions and system downtimes.
“The system has been down for about 15 minutes and so a customer’s prescription was dispensed without assistance from the computer. The pharmacist has been on the phone twice to complain and it is currently being seen to.” [32]
Several issues with e-prescription systems were highlighted, including outdated information and automated default settings which limited user control and created discrepancies with prescribers’ intentions [50,53,54,58].
“Technician: “We hear a lot when I call, it defaulted into that, or I don’t know how to get that out of there. So I’m thinking they don’t have a lot of control sometimes.”
Technician: “They tend not to take their notes off new ones. If they fax over something, they’ll say, patient needs to be seen before more refills, but they’ll give them a year’s worth of refills. And then we find out that that note is old, and they just didn’t take it off the e-script.” [54]
Subtheme: Absence of automation and technology in community pharmacies and limited integration with other healthcare institutions.
Pharmacists noted that the lack of patient records, electronic prescribing, or automation in pharmacies increases the risk of medication errors [31,33,57]. They also highlighted that the absence of an integrated system connecting pharmacies, patients, and insurance providers could result in duplicate prescriptions and potential harm [33].
“There should be a special file for each patient in each pharmacy, not only in the hospital.” (Community pharmacy group-1) [33]
Study quality appraisal:
All 13 assessed studies satisfied the criteria related to the clarity of the research aims and findings, the appropriateness of the qualitative methodology and the value of the research [31–33,50–59]. Nevertheless, 12 studies lacked sufficient information regarding whether the relationship between the researcher and the participants was considered [31–33,50–59]. Moreover, six studies did not meet the criterion assessing on whether the data was collected in a way that addressed the research issue [31,32,50,51,54,57]. The details of the quality appraisal are outlined in S4 File.
Confidence in the synthesised findings
The GRADE-CERQual confidence in the synthesised findings are depicted in S5 File.
Discussion
While previous reviews have investigated the factors or causes of medication errors in community pharmacies [60–62], this study is the first meta-ethnographic systematic review to assess the causes of medication errors in the community pharmacy setting. The overarching themes developed in this work demonstrated the multifaceted causes of such errors, ranging from pharmacist-related factors to organisational- and management- related factors.
Shortage of staff, high workload and interruptions were frequently reported contributors to medication errors in community pharmacies. Pharmacies are often considered as busy and fast-paced environments where interruptions in workflow are common [63–66]; such disruptions have been deemed to impact on pharmacists’ ability to concentrate, especially when engaged in highly cognitive medication safety activities, such as the clinical review of prescriptions [63,65,67]. Well-structured workspaces have been recognised to enhance pharmacists’ focus and to reduce the potential of medication errors [68,69], echoing the findings from this work. Staff shortages and increases in patient numbers have been recognised as attributing to rises in workload [70–72], thereby reducing time allocated for individual patient care and potentially compromising patient safety. To address these challenges, several interventions may be considered. These include redesigning pharmacy facilities to separate order entry, dispensing, and prescription checking activities and introducing non-interruption zones for tasks that require sustained concentration [73]. System level changes may also be effective such as implementing dispensing tracking systems, automated dispensing technologies, and a pharmacy services call centre staffed by pharmacy technicians, alongside protected checking time to minimise interruptions during cognitively demanding tasks [73]. In addition, staff training and role standardisation could support efficient workload management [74]. For instance, assigning staff to specific work areas based on task urgency and ensuring they acquire the competencies needed for their roles [74]. Providing pharmacists with access to prescribers’ electronic health records may further improve workflow efficiency [73]. Moreover, structured task allocation across the pharmacy team and proactive workforce planning to maintain a tolerable workload are also likely to contribute to safer practice. [73–75].
Moreover, this review recognised several organisational-, cultural- and communication- related factors contributing to medication errors in community pharmacies. A culture of error concealment, underreporting, and reliance on informal mechanisms for mitigating incidents echoed previous studies [76,77], specifically fear of professional or disciplinary consequences, a lack of trust in the fairness of regulatory systems and fear of personal blame [78–80]. The presence of a blame culture has been well-documented as a barrier to medication safety across various healthcare settings [79,81,82]. Adding to these challenges is the tendency of pharmacists in this review to prioritise their professional judgement over adherence to policies and standardised protocols [31,33,59].Several published studies depicted circumstances in which pharmacists deviated from protocols, indicating a potential contradiction between pharmacists’ perceptions of the best course of action and regulatory requirements [31,83]. Pharmacists’ clinical decision making and compliance with protocols can be influenced by various factors including pharmacists’ experience, the patient’s clinical context and protocol obsolescence [31,83]. This review also noted protocol obsolescence as a reason for non-adherence. Wider studies have shown that while pharmacists’ actions often indicate their dedication to medication safety, dependence on outdated guidance or divergence from policies has been associated with an increased risk for adverse events [75,84]. Hence, it is essential to regularly review and update pharmacy policies to ensure alignment with the latest advancements in community pharmacy practice. This study also highlighted the centralised role of chain pharmacies in promoting patient safety by implementing standardised policies and procedures and sharing resources across multiple branches. However, similar to other studies [62,68,85], it pointed out that communication gaps between pharmacy branches and among staff contribute to medication errors. Effective team communication is key for establishing a patient safety culture [86,87]. Pharmacy management should assess the impact of communication gaps to identify areas requiring improvement [88]. Addressing deficiencies in team communication, specifically those affecting collaboration, patient information exchange, and responsibility for patient care, is vital. Hence, strategies such as promoting open discussions, implementing dedicated committees, and conducting regular briefings should form integral components of any patient safety intervention within the community pharmacy sector [88]. Collectively, these review findings emphasise the importance of adopting a patient safety culture defined by adherence to SOPs for error reporting and supported by a blame-free, non-punitive and learning environment [75].
The study findings also raised concerns regarding pharmacist–patient communication including the possible association between medication errors and language barriers. Previous evidence has demonstrated inequity around access to medications and healthcare services for people with cultural and linguistic diversity [89–92], exposing certain populations of people to a greater risk of medication errors and adverse effects [93]. Further, inequalities relating to involvement in decision-making processes about medicines have been demonstrated amongst people experiencing minoritisation, which further increases the potential of medication errors [45,94,95]. There is a growing need for pharmacists to embrace communication and involvement strategies aligned with patients’ needs and therapeutic goals [96,97], with the ultimate aim of achieving optimal health outcomes [96,97]. Echoing previous studies [62,98], difficulty in communicating with prescribers was also identified as a factor negatively impacting medication safety and patient outcomes. [99] Several factors may contribute to these challenges including limited physician time, attitudes regarding pharmacists’ inadequate competency and physicians’ self-perception of sole responsibility for medications [100].Facilitating pharmacist access to the patients’ electronic medical records could serve as a potential solution to overcome this barrier [101]. Furthermore, implementing a collaborative care model, starting with training the pharmacists, improving the physicians’ awareness of the pharmacists’ role, followed by cultivating their professional recognition and commitment, may further assist in collaborative care efforts [100–102].
This review identified human factors such as lapses in attention, memory failures, and deficiencies in medication preparation and dispensing processes as contributors to medication errors. These findings are consistent with current literature, which highlights cognitive errors as a prevalent cause of medication errors in community pharmacy settings [62]. Medication management is a cognitively demanding process involving clinical reasoning, reflective thinking, problem-solving, and decision-making [98]. These aspects fall under the domain of cognitive ergonomics, which is a discipline that studies how cognitive processes influence interactions among humans and performance in complex tasks [103]. According to this discipline, when individuals are required to perform multiple high-level cognitive tasks, particularly in high-pressure environments, memory lapses are more likely to occur [104]. Consequently, relying solely on memory and attention increases the risk of medication errors. To mitigate this, SOPs a well-organised distribution of duties among pharmacy staff and integrating technological solutions can decrease individual cognitive burden and minimise the risk of human errors [75]..
Additionally, this review highlighted how both patient- driven and commercial pressure can affect medication safety in community pharmacy practice. Pharmacists often face demands to dispense medication rapidly which may limit the time available for thorough review of prescriptions which is an essential step to prevent errors [105]. Furthermore, financial and commercial pressure, especially from the pharmaceutical industry, can significantly influence prescribing behaviours and clinical decision making potentially misaligning with patients’ best interests, compromising their safety and increasing healthcare costs [106,107]. Tackling these challenges necessitates multi-dimensional interventions including public awareness campaigns to support the role of pharmacists in prescriptions’ review, pharmacy workflow improvement, designated clinical review spaces, and pharmacists’ training on effective management of patient pressure [88]. Regulatory strategies are also needed to reduce undue influence of pharmaceutical industry [108,109] and to ensure that treatment decisions are guided by clinical evidence and cost-effectiveness studies [110].
Absence of pharmacy automation and the limited integration of community pharmacy systems with other healthcare institutions were also found to contributing factors to medication errors. In fragmented care settings, pharmacists often lack access to electronic health records increasing the risk for drug duplication and patient harm [111,112] Implementing technological solutions in community pharmacies is crucial and automation offers several advantages, including reduced prescription filling time [113,114], enhanced productivity and dispensing efficiency, and overall healthcare cost savings [115,116]. However, technology is not without risks [116,117].E-prescribing systems may compromise medication safety, particularly when outdated prescription information is auto-populated and is electronically transmitted to pharmacies as identified in this review and in prior studies [62]. Design and functionality limitations in e-prescribing and dispensing technologies were noted to disrupt workflow and impair community pharmacists’ ability to deliver safe and effective care. Overcoming these problems requires changes to existing technological systems in community pharmacies including the establishment of effective communication channels between prescribers and pharmacists [50]. Adherence to evidence-based best practices and guidelines for safe electronic communication of medication information such as those issued by the Institute for Safe Medication Practices (ISMP) is also essential [50,118]. Providing training for both prescribers and community pharmacists on the optimal use of electronic prescribing and dispensing systems may also reduce misunderstanding and contribute to the prevention of medication errors [119].
This review presents several findings with notable implications for community pharmacy practice and future research. The overarching third-order constructs developed from the synthesis indicate that an intricate interplay of factors contributes to medication errors in community pharmacy settings. Further research is warranted to explore the interrelationships among these factors given the inherent complexity of community pharmacy environments. Mapping these connections is a critical step in designing effective interventions. Future studies should similarly focus on identifying the best frameworks for implementing quality and safety strategies and evaluating their impact in real-life settings.
Strengths and limitations
This review has numerous strengths. Firstly, it represents the first meta-ethnography of the causes of medication errors within community pharmacies. Secondly, the methodological rigor of the review process, as the findings were reported in accordance with the PRISMA guidelines [34] and the eMERGe framework [35]. Moreover, the review used an extensive search strategy that was not restricted by language or publication date and included supplementary searches thereby enhancing the robustness of the search. However, only a limited number of studies reporting qualitative data were identified within the wider literature, emphasising the need for additional qualitative research in this area. Furthermore, the majority of studies were conducted in the United Kingdom and the United States which may limit the generalisability of the results to other areas.
Conclusions
Recognising opportunities to enhance medication safety in community pharmacies requires a thorough examination of the factors contributing to medication errors in this setting. This meta-ethnographic systematic review synthesised qualitative findings and developed five third-order constructs that capture the underlying causes of such errors. These constructs include pharmacist-related factors, the environment within the pharmacy, management and financial related factors, organisational and social environment within the pharmacy and challenges with digital technologies The findings have important implications for policymakers, healthcare leaders, pharmacy managers, and community pharmacists as they design and implement quality and safety interventions tailored to these domains. Further research is necessary to deepen our understanding of the interrelationships among these factors which is essential for the creation of effective context-sensitive interventions and for evaluating their impact on medication safety in real-world community pharmacy practice.
Supporting information
S2 File. The eMERGe checklist for meta-ethnography.
https://doi.org/10.1371/journal.pone.0349120.s002
(DOC)
S4 File. Results of the risk of bias assessment of the included studies.
https://doi.org/10.1371/journal.pone.0349120.s004
(DOC)
References
- 1.
Patient Safety Key Facts: World Health Organization. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/patient-safety
- 2. Hodkinson A, Tyler N, Ashcroft DM, Keers RN, Khan K, Phipps D, et al. Preventable medication harm across health care settings: a systematic review and meta-analysis. BMC Med. 2020;18(1):313. pmid:33153451
- 3.
Prevention NCCfMERa. About Medication Errors What is a Medication Error? Available from: https://www.nccmerp.org/about-medication-errors
- 4.
Organization WH. Medication Without Harm. World Health Organization; 2025. Available from: https://www.who.int/initiatives/medication-without-harm
- 5.
AHRQ-Funded Patient Safety Project Highlights. 2024 [Available from: https://www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
- 6. Hong K, Hong YD, Cooke CE. Medication errors in community pharmacies: The need for commitment, transparency, and research. Res Social Adm Pharm. 2019;15(7):823–6. pmid:30555008
- 7. Berenbrok LA, Tang S, Gabriel N, Guo J, Sharareh N, Patel N, et al. Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis. J Am Pharm Assoc (2003). 2022;62(6):1816-1822.e2. pmid:35965233
- 8.
R B. Community pharmacy England pharmacy advice audit 2024. United Kingdom: Community Pharmacy England; 2024.
- 9. Carson-Chahhoud KV, Livingstone-Banks J, Sharrad KJ, Kopsaftis Z, Brinn MP, To-A-Nan R, et al. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2019;2019(10):CD003698. pmid:31684695
- 10. Aly M, García-Cárdenas V, Williams K, Benrimoj SI. A review of international pharmacy-based minor ailment services and proposed service design model. Res Social Adm Pharm. 2018;14(11):989–98. pmid:29444752
- 11. Ali ZZ, Assifi AR, Skouteris H, Pirotta S, Hussainy SY. Community pharmacists improving equitable access to contraceptive methods: a commentary. Int J Clin Pharm. 2025;47(2):477–83. pmid:39982543
- 12. Burson RC, Buttenheim AM, Armstrong A, Feemster KA. Community pharmacies as sites of adult vaccination: A systematic review. Hum Vaccin Immunother. 2016;12(12):3146–59. pmid:27715409
- 13. Cahyaningsih I, Lambert M, Ochi T, Li F, Li X, Denig P, et al. Community pharmacist-led interventions for patients with type 2 diabetes in low-income and middle-income countries: A scoping review. Res Social Adm Pharm. 2023;19(8):1117–30. pmid:37270326
- 14. Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78(6):1238–47. pmid:24966032
- 15. El Hajj MS, Asiri R, Husband A, Todd A. Medication errors in community pharmacies: a systematic review of the international literature. PLoS One. 2025;20(5):e0322392. pmid:40392881
- 16. Greene R. Survey of prescription anomalies in community pharmacies: (1) Prescription monitoring. Pharm J. 1995;254(6835):476–81.
- 17. Drankowska J, Krysiński J, Płaczek J, Czerw A, Religioni U, Merks P. Evaluation of the prescribing patterns of paediatric medications in polish community pharmacies. Acta Pol Pharm Drug Res. 2021;78(2):279–87.
- 18. Teagarden JR, Nagle B, Aubert RE, Wasdyke C, Courtney P, Epstein RS. Dispensing error rate in a highly automated mail-service pharmacy practice. Pharmacotherapy. 2005;25(11):1629–35. pmid:16232024
- 19. Allan EL, Barker KN, Malloy MJ, Heller WM. Dispensing errors and counseling in community practice. Am Pharm. 1995;NS35(12):25–33. pmid:8546071
- 20. Marwaha M, Wadhwa J, Padi SSV. A retrospective analysis on a survey of handwritten prescription errors in general practice. Int J Pharm Pharmaceut Sci. 2010;2:80–2.
- 21. Teinilä T, Grönroos V, Airaksinen M. Survey of dispensing error practices in community pharmacies in Finland: a nationwide study. J Am Pharm Assoc (2003). 2009;49(5):604–10. pmid:19748866
- 22. Franklin BD, O’Grady K. Dispensing errors in community pharmacy: frequency, clinical significance and potential impact of authentication at the point of dispensing. Int J Pharm Pract. 2007;15(4):273–81.
- 23. Al-worafi YM. Dispensing Errors Observed By Community Pharmacy Dispensers In IBB - Yemen. Asian J Pharm Clin Res. 2018;11(11):478.
- 24. Al-Worafi YM, Alseragi WM, Seng LK, Kassab YW, Yeoh SF, Ming LC. Dispensing errors in community pharmacies: A prospective study in Sana’a, Yemen. Arch Pharm Pract. 2018;9(4):1–3.
- 25. Sarhangia N, Zakerian SA, Afzali M. Influential factors on pharmacist profession-related errors: A community pharmacy approach. Iranian J Pharmaceut Sci. 2021;17(1):19–26.
- 26. Witte D, Dundes L. Prescription for error: process defects in a community retail pharmacy. J Patient Saf. 2007;3(4):190–4.
- 27. Ashcroft DM, Quinlan P, Blenkinsopp A. Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies. Pharmacoepidemiol Drug Saf. 2005;14(5):327–32. pmid:15386722
- 28. Adie K, Fois RA, McLachlan AJ, Walpola RL, Chen TF. The nature, severity and causes of medication incidents from an Australian community pharmacy incident reporting system: The QUMwatch study. Br J Clin Pharmacol. 2021;87(12):4809–22. pmid:34022060
- 29. Coblio NA, McCright P, Centeno G, Mowrey K. Systems Evaluation and pharmacy redesign needed in addressing medication errors. J Am Pharm Assoc (2003). 2005;45(1):4, 6. pmid:15730107
- 30. Rashdan D, Farha RA, Yasin H, Hadi MA. Human factors frameworks in analysis of contributory factors to medication error: A systematic review. Res Social Adm Pharm. 2025;21(9):629–52. pmid:40320337
- 31. Phipps DL, Noyce PR, Parker D, Ashcroft DM. Medication safety in community pharmacy: a qualitative study of the sociotechnical context. BMC Health Serv Res. 2009;9:158. pmid:19735550
- 32. Harvey J, Avery AJ, Ashcroft D, Boyd M, Phipps DL, Barber N. Exploring safety systems for dispensing in community pharmacies: focusing on how staff relate to organizational components. Res Social Adm Pharm. 2015;11(2):216–27. pmid:25108523
- 33. Al Juffali L, Al-Aqeel S, Knapp P, Mearns K, Family H, Watson M. Using the Human Factors Framework to understand the origins of medication safety problems in community pharmacy: A qualitative study. Res Social Adm Pharm. 2019;15(5):558–67. pmid:30031695
- 34. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. pmid:33782057
- 35. France EF, Cunningham M, Ring N, Uny I, Duncan EAS, Jepson RG, et al. Improving reporting of meta-ethnography: the eMERGe reporting guidance. BMC Med Res Methodol. 2019;19(1):25. pmid:30709371
- 36. Sattar R, Lawton R, Panagioti M, Johnson J. Meta-ethnography in healthcare research: a guide to using a meta-ethnographic approach for literature synthesis. BMC Health Serv Res. 2021;21(1):50. pmid:33419430
- 37.
Fathelrahman AI, Ibrahim MIM, Wertheimer AI. Front matter. Pharmacy Practice in Developing Countries. Boston: Academic Press; 2016. iii p.
- 38.
CASP C. CASP qualitative checklist. Critical Appraisal Skills Programme. 2018.
- 39.
Noblit GW. Meta-ethnography: synthesizing qualitative studies. California, USA: SAGE Publishing; 1988.
- 40. Britten N, Campbell R, Pope C, Donovan J, Morgan M, Pill R. Using meta ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy. 2002;7(4):209–15. pmid:12425780
- 41. Campbell R, Pound P, Morgan M, Daker-White G, Britten N, Pill R, et al. Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research. Health Technol Assess. 2011;15(43):1–164. pmid:22176717
- 42. Campbell R, Pound P, Pope C, Britten N, Pill R, Morgan M, et al. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc Sci Med. 2003;56(4):671–84. pmid:12560003
- 43. Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55. pmid:15847968
- 44. Robinson A, Oksuz U, Slight R, Slight S, Husband A. Digital and Mobile Technologies to Promote Physical Health Behavior Change and Provide Psychological Support for Patients Undergoing Elective Surgery: Meta-Ethnography and Systematic Review. JMIR Mhealth Uhealth. 2020;8(12):e19237. pmid:33258787
- 45. Asiri R, Robinson-Barella A, Iqbal A, Todd A, Husband A. Understanding the influence of ethnicity on adherence to antidiabetic medication: Meta-ethnography and systematic review. PLoS One. 2023;18(10):e0292581. pmid:37824483
- 46. France EF, Cunningham M, Ring N, Uny I, Duncan EAS, Jepson RG, et al. Improving reporting of meta-ethnography: the eMERGe reporting guidance. BMC Med Res Methodol. 2019;19(1):25. pmid:30709371
- 47. Lewin S, Booth A, Glenton C, Munthe-Kaas H, Rashidian A, Wainwright M, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series. Implement Sci. 2018;13(Suppl 1):2. pmid:29384079
- 48. Family H. The effects of mental workload on medicines safety in a community pharmacy setting. England: University of Bath; 2013.
- 49.
Kousar S. An examination of the causes, contributory factors and consequences of dispensing errors in community pharmacy, and the experiences of community pharmacists in ensuring accuracy during the dispensing process. England: Aston University; 2019.
- 50. Hincapie AL, Alamer A, Sears J, Warholak TL, Goins S, Weinstein SD. A Quantitative and Qualitative Analysis of Electronic Prescribing Incidents Reported by Community Pharmacists. Appl Clin Inform. 2019;10(3):387–94. pmid:31167250
- 51. Clabaugh M, Newlon JL, Illingworth Plake KS. Perceptions of working conditions and safety concerns in community pharmacy. J Am Pharm Assoc. 2021;61(6):761–71.
- 52. Odukoya O, Chui MA. Retail pharmacy staff perceptions of design strengths and weaknesses of electronic prescribing. J Am Med Inform Assoc. 2012;19(6):1059–65. pmid:22753809
- 53. Odukoya OK, Chui MA. e-Prescribing: characterisation of patient safety hazards in community pharmacies using a sociotechnical systems approach. BMJ Qual Saf. 2013;22(10):816–25. pmid:23708439
- 54. Odukoya OK, Stone JA, Chui MA. E-prescribing errors in community pharmacies: exploring consequences and contributing factors. Int J Med Inform. 2014;83(6):427–37. pmid:24657055
- 55. Whitaker M, Lester C, Rowell B. Handing off electronic prescription data from prescribers to community pharmacies: A qualitative analysis of pharmacy staff perspectives. J Patient Saf. 2024;20(6):397–403.
- 56. Phipps DL, Jones CEL, Parker D, Ashcroft DM. Organizational conditions for engagement in quality and safety improvement: a longitudinal qualitative study of community pharmacies. BMC Health Serv Res. 2018;18(1):783. pmid:30333018
- 57. Wang Y, Ram SS, Scahill S. Understanding Risk Factors for Complaints Against Pharmacists: A Content Analysis. J Patient Saf. 2024;20(4):e18–28. pmid:38506483
- 58. Lester CA, Kessler JM, Modisett T, Chui MA. A text mining analysis of medication quality related event reports from community pharmacies. Res Social Adm Pharm. 2019;15(7):845–51. pmid:30287218
- 59. Jones CEL, Phipps DL, Ashcroft DM. Understanding procedural violations using Safety-I and Safety-II: The case of community pharmacies. Saf Sci. 2018;105:114–20. pmid:29861550
- 60. Assiri GA, Shebl NA, Mahmoud MA, Aloudah N, Grant E, Aljadhey H, et al. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018;8(5):e019101. pmid:29730617
- 61. James KL, Barlow D, McArtney R, Hiom S, Roberts D, Whittlesea C. Incidence, type and causes of dispensing errors: a review of the literature. Int J Pharm Pract. 2009;17(1):9–30. pmid:20218026
- 62. Weir NM, Newham R, Bennie M. A literature review of human factors and ergonomics within the pharmacy dispensing process. Res Social Adm Pharm. 2020;16(5):637–45. pmid:31444123
- 63. Reddy A, Abebe E, Rivera AJ, Stone JA, Chui MA. Interruptions in community pharmacies: Frequency, sources, and mitigation strategies. Res Social Adm Pharm. 2019;15(10):1243–50. pmid:30420227
- 64. Ashcroft DM, Quinlan P, Blenkinsopp A. Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies. Pharmacoepidemiol Drug Saf. 2005;14(5):327–32. pmid:15386722
- 65. Flynn EA, Barker KN, Gibson JT, Pearson RE, Berger BA, Smith LA. Impact of interruptions and distractions on dispensing errors in an ambulatory care pharmacy. Am J Health Syst Pharm. 1999;56(13):1319–25. pmid:10683129
- 66. Odukoya OK, Stone JA, Chui MA. Barriers and facilitators to recovering from e-prescribing errors in community pharmacies. J Am Pharm Assoc (2003). 2015;55(1):52–8. pmid:25539495
- 67. Chui MA, Mott DA. Community pharmacists’ subjective workload and perceived task performance: a human factors approach. J Am Pharm Assoc (2003). 2012;52(6):e153-60. pmid:23229977
- 68. Szeinbach S, Seoane-Vazquez E, Parekh A, Herderick M. Dispensing errors in community pharmacy: perceived influence of sociotechnical factors. Int J Qual Health Care. 2007;19(4):203–9. pmid:17567597
- 69. Rapport F, Doel MA, Jerzembek GS. “Convenient space” or “a tight squeeze”: insider views on the community pharmacy. Health Place. 2009;15(1):315–22. pmid:18675577
- 70. Francis SG. Pharmacists’ Perceptions About the Effect of Work Environment Factors on Patient Safety in Large-Chain Retail Pharmacies. J Pharm Technol. 2022;38(6):376–8. pmid:36311301
- 71. Martello JL, Dumont Z, Bruck W, Buckley MS, Buckley CT, Centanni N, et al. Identifying ideal pharmacist‐to‐patient ratios for the successful provision of clinical pharmacy services. J Am Coll Clin Pharm. 2024;7(5):505–16.
- 72. Pervanas HC, Revell N, Alotaibi AF. Evaluation of Medication Errors in Community Pharmacy Settings: A Retrospective Report. J Pharm Technol. 2016;32(2):71–4. pmid:34861023
- 73. Ayanaw M, Lim A, Khera H, Vu T, Goordeen D, Malone D. How do interruptions and distractions affect pharmacy practice? A scoping review of their impact and interventions in dispensing. Res Social Adm Pharm. 2025;21(9):667–78. pmid:40404487
- 74. Shao S-C, Chan Y-Y, Lin S-J, Li C-Y, Kao Yang Y-H, Chen Y-H, et al. Workload of pharmacists and the performance of pharmacy services. PLoS One. 2020;15(4):e0231482. pmid:32315319
- 75.
ISMP. Improving Medication Safety in Community Pharmacy: Assessing Risk and Opportunities for Change: Institute for Safe Practices: a nonprofit organization; 2009. Available from: https://www.ismp.org/sites/default/files/attachments/2018-02/ISMP_AROC_whole_document.pdf
- 76. Ashcroft DM, Morecroft C, Parker D, Noyce PR. Likelihood of reporting adverse events in community pharmacy: an experimental study. Qual Saf Health Care. 2006;15(1):48–52. pmid:16456210
- 77. Naseralallah L, Stewart D, Price M, Paudyal V. Prevalence, contributing factors, and interventions to reduce medication errors in outpatient and ambulatory settings: a systematic review. Int J Clin Pharm. 2023;45(6):1359–77.
- 78. Shalviri G, Mohebbi N, Mirbaha F, Majdzadeh R, Yazdizadeh B, Gholami K, et al. Improving adverse drug event reporting by healthcare professionals. Cochrane Database Syst Rev. 2024;10(10):CD012594. pmid:39470185
- 79. Braiki R, Douville F, Gagnon M-P. Factors influencing the reporting of medication errors and near misses among nurses: A systematic mixed methods review. Int J Nurs Pract. 2024;30(6):e13299. pmid:39225448
- 80.
Wolf ZR, Hughes R. Error reporting and disclosure. In: Hughes R, editor. Patient safety and quality: An evidence-based handbook for nurses. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008.
- 81. Holmström A-R, Airaksinen M, Weiss M, Wuliji T, Chan XH, Laaksonen R. National and local medication error reporting systems: a survey of practices in 16 countries. J Patient Saf. 2012;8(4):165–76. pmid:23007239
- 82. Afaya A, Konlan KD, Kim Do H. Improving patient safety through identifying barriers to reporting medication administration errors among nurses: an integrative review. BMC Health Serv Res. 2021;21(1):1156. pmid:34696788
- 83. Mertens JF, Koster ES, Deneer VHM, Bouvy ML, van Gelder T. Factors influencing pharmacists’ clinical decision making in pharmacy practice. Res Social Adm Pharm. 2023;19(9):1267–77. pmid:37236847
- 84. Phipps DL, Parker D, Pals EJM, Meakin GH, Nsoedo C, Beatty PCW. Identifying violation-provoking conditions in a healthcare setting. Ergonomics. 2008;51(11):1625–42. pmid:18941971
- 85. Ashcroft DM, Parker D. Development of the pharmacy safety climate questionnaire: a principal components analysis. Qual Saf Health Care. 2009;18(1):28–31. pmid:19204128
- 86. Radwan L, Salameh P. Evaluation of patient safety culture in community pharmacies. Explor Res Clin Soc Pharm. 2023;10:100260. pmid:37396109
- 87. Aboneh EA, Stone JA, Lester CA, Chui MA. Evaluation of Patient Safety Culture in Community Pharmacies. J Patient Saf. 2020;16(1):e18–24. pmid:29112024
- 88.
Improving Patient Safety in Community Pharmacies: A Resource List for Users of the AHRQ Community Pharmacy Survey on Patient Safety Culture. [cited 2025-04-28]. Available from: https://www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/community-pharmacy/pharmacy-resources.pdf
- 89. Robinson A, Elarbi M, Todd A, Husband A. A qualitative exploration of the barriers and facilitators affecting ethnic minority patient groups when accessing medicine review services: Perspectives of healthcare professionals. Health Expect. 2022;25(2):628–38. pmid:34951087
- 90. Robinson A, Sile L, Govind T, Guraya HK, O’Brien N, Harris V, et al. “He or she maybe doesn’t know there is such a thing as a review”: A qualitative investigation exploring barriers and facilitators to accessing medication reviews from the perspective of people from ethnic minority communities. Health Expect. 2022;25(4):1432–43. pmid:35384182
- 91. Robinson A, O’Brien N, Sile L, Guraya HK, Govind T, Harris V, et al. Recommendations for community pharmacy to improve access to medication advice for people from ethnic minority communities: A qualitative person-centred codesign study. Health Expect. 2022;25(6):3040–52. pmid:36161966
- 92. Peled Y. Language barriers and epistemic injustice in healthcare settings. Bioethics. 2018;32(6):360–7. pmid:29741210
- 93. Al Shamsi H, Almutairi AG, Al Mashrafi S, Al Kalbani T. Implications of Language Barriers for Healthcare: A Systematic Review. Oman Med J. 2020;35(2):e122. pmid:32411417
- 94. Begum T, Murrell K, Robinson-Barella A. Tackling Inequalities in Access to Medicines for People Experiencing Homelessness: A Meta-Ethnography and Qualitative Systematic Review. Health Expect. 2024;27(5):e70076. pmid:39451019
- 95. Robinson-Barella A, Richardson CL, Bayley Z, Husband A, Bojke R, Bojke A, et al. “Do I actually even need all these tablets?” A qualitative study exploring deprescribing decision-making for people in receipt of palliative care and their family members. Palliat Med. 2025;39(5):543–52. pmid:40167136
- 96. Wolters M, van Hulten R, Blom L, Bouvy ML. Exploring the concept of patient centred communication for the pharmacy practice. Int J Clin Pharm. 2017;39(6):1145–56. pmid:28887610
- 97. Kenny KPR. Communication skills are crucial for patient safety. Pharmacy Times. 2024;90.
- 98. Adie K, Fois RA, McLachlan AJ, Walpola RL, Chen TF. The nature, severity and causes of medication incidents from an Australian community pharmacy incident reporting system: The QUMwatch study. Br J Clin Pharmacol. 2021;87(12):4809–22. pmid:34022060
- 99. Vermeir P, Vandijck D, Degroote S, Peleman R, Verhaeghe R, Mortier E, et al. Communication in healthcare: a narrative review of the literature and practical recommendations. Int J Clin Pract. 2015;69(11):1257–67. pmid:26147310
- 100. Löffler C, Koudmani C, Böhmer F, Paschka SD, Höck J, Drewelow E, et al. Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study. BMC Health Serv Res. 2017;17(1):224. pmid:28327136
- 101. White A, Fulda KG, Blythe R, Chui MA, Reeve E, Young R, et al. Defining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety. Expert Opin Drug Saf. 2022;21(11):1357–64. pmid:36377503
- 102. McDonough RP, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc. 2001;41(5):682–91.
- 103. Karwowski W. Ergonomics and human factors: the paradigms for science, engineering, design, technology and management of human-compatible systems. Ergonomics. 2005;48(5):436–63. pmid:16040519
- 104. McDowell SE, Ferner HS, Ferner RE. The pathophysiology of medication errors: how and where they arise. Br J Clin Pharmacol. 2009;67(6):605–13. pmid:19594527
- 105.
The Pharmacist’s Role in Medication Safety. PSNet [internet]. 2019.
- 106. Fadlallah R, Alkhaled L, Brax H, Nasser M, Rajabbik MH, Nass H, et al. Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review. Eur J Public Health. 2018;28(2):224–30. pmid:29165586
- 107. Chimonas S, Mamoor M, Zimbalist SA, Barrow B, Bach PB, Korenstein D. Mapping conflict of interests: scoping review. BMJ. 2021;375:e066576. pmid:34732464
- 108. Zarei E, Ghaffari A, Nikoobar A, Bastami S, Hamdghaddari H. Interaction between physicians and the pharmaceutical industry: A scoping review for developing a policy brief. Front Public Health. 2022;10:1072708. pmid:36711334
- 109. Owens DK, Qaseem A, Chou R, Shekelle P, Clinical Guidelines Committee of the American College of Physicians. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med. 2011;154(3):174–80. pmid:21282697
- 110.
Association AP. Pharmacists’ Impact on Patient Safety: A Joint Project of the American Pharmacists Association Academy of Pharmacy Practice and Management and Academy of Pharmaceutical Research and Science. Washington, DC: American Pharmacists Association; 2016 [cited 2025-04-28]. Available from: https://www.pharmacist.com/Portals/0/PDFS/Practice/PharmacistsImpactonPatientSafety_Web.pdf?ver=dYeAzwlN3-PG9eSkMMsV-A%3D%3D
- 111. Husband A, Robinson-Barella A. Integration and connection: the key to effectiveness of large-scale pharmacist-led medication reviews? BMJ Qual Saf. 2024;33(12):765–8. pmid:39214679
- 112. Kern LM, Bynum JPW, Pincus HA. Care Fragmentation, Care Continuity, and Care Coordination-How They Differ and Why It Matters. JAMA Intern Med. 2024;184(3):236–7. pmid:38285559
- 113. Walsh KE, Chui MA, Kieser MA, Williams SM, Sutter SL, Sutter JG. Exploring the impact of an automated prescription-filling device on community pharmacy technician workflow. J Am Pharm Assoc (2003). 2011;51(5):613–8. pmid:21896459
- 114. Lin AC, Huang Y-C, Punches G, Chen Y. Effect of a robotic prescription-filling system on pharmacy staff activities and prescription-filling time. Am J Health Syst Pharm. 2007;64(17):1832–9. pmid:17724365
- 115. Sng Y, Ong CK, Lai YF. Approaches to outpatient pharmacy automation: a systematic review. Eur J Hosp Pharm. 2019;26(3):157–62. pmid:31428324
- 116. Esmaeil Zadeh P, Tremblay MC. A review of the literature and proposed classification on e-prescribing: Functions, assimilation stages, benefits, concerns, and risks. Res Social Adm Pharm. 2016;12(1):1–19. pmid:25847858
- 117. Hareem A, Lee J, Stupans I, Park JS, Wang K. Benefits and barriers associated with e-prescribing in community pharmacy - A systematic review. Explor Res Clin Soc Pharm. 2023;12:100375. pmid:38145236
- 118.
ISMP. ISMP Guidelines for Safe Electronic Communication of Medication Information. 2019 [cited 2025-05-06]. Available from: https://online.ecri.org/hubfs/ISMP/Resources/ISMP_Electronic_Guidelines.pdf
- 119. Brown CL, Reygate K, Slee A, Coleman JJ, Pontefract SK, Bates DW, et al. A literature review of the training offered to qualified prescribers to use electronic prescribing systems: why is it so important? Int J Pharm Pract. 2017;25(3):195–202. pmid:27488258